West Enclave Merger Corp. has 2 Schedule 13D or 13G filings on record since 2026-05-12. 2 holders' latest filing reports 5% or more of ordinary shares, par value $0.0001 per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| West Enclave Sponsor, LLC | 16.2% | 2,603,333 | SCHEDULE 13D, 2026-05-12 | 2026-05-01 |
| Adage Capital Management, L.P. | 5.61% | 900,000 | SCHEDULE 13G, 2026-08-12 | 2026-06-30 |
Purpose of Transaction (Item 4)
West Enclave Sponsor, LLC
On December 17, 2025, the Issuer issued an aggregate of 3,833,333 ordinary shares to Sponsor for an aggregate purchase price of $25,000. Third party designees of the sponsor purchased an aggregate of 147,500 of the private units Sponsor purchased, Jean-Michel Enriquez Dahlhaus, one of the Issuer's independent directors, purchased 5,000 of the private units Sponsor has purchased, and an entity affiliated with Hector Madero Rivero, another of the Issuer's independent directors, has purchased 20,000 of the private units Sponsor purchased, in each case at $10.00 per private unit. Sponsor transferred an aggregate of 1,380,000 ordinary shares of the Issuer (the "founder shares") on the closing of the initial public offering for an aggregate consideration of approximately $9,000, or approximately $0.0065 per founder share (including 40,000 founder shares to Mr. Enriquez and 160,000 founder shares to the entity affiliated with Mr. Madero). On May 1, 2026, the Issuer consummated its initial public offering ("IPO") and in connection with the consummation, Sponsor purchased an aggregate of 300,000 units for an aggregate purchase price of $3,000,000. On May 4, 2026, the underwriters of the Issuer, notified the Company of their exercise of the over-allotment option in full and purchased 1,500,000 additional units at $10.00 per unit upon the closing of the over-allotment option, generating gross proceeds of $15,000,000. The over-allotment option closed on May 6, 2026 simultaneously with a …The first part of Item 4 of the SCHEDULE 13D filed 2026-05-12; the filing has the rest
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2026-05-12 | West Enclave Sponsor, LLC | 16.2% | SCHEDULE 13D |
| 2026-08-12 | Adage Capital Management, L.P. | 5.61% | SCHEDULE 13G |
Tools for this story
Each opens in a new tab, filled in for West Enclave Merger Corp.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.